Efficacy of Dupilumab in severe Atopic Dermatitis (AD) using the AD Control Tool (ADCT) Score in the population of Qatar

Atopic Dermatitis (AD) is a high-burden disease that affects approximately 2–5% of adults. AD patients experience intense pruritus and often report sleep and mental health disturbances accompanied by a diminished quality of life. The patients’ perceptions of their treatment benefits are becoming inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Joy, Febu, AlKhawaga, Sara, Iqneibi, Maryam, Marri, Fahad Al, Chalabi, Radi Al, Buddenkotte, Joerg, Steinhoff, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: HBKU Press 2023
Materias:
Second Qatar Allergy Conference
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660452/
https://www.ncbi.nlm.nih.gov/pubmed/38025319
http://dx.doi.org/10.5339/qmj.2023.sqac.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660452/
https://www.ncbi.nlm.nih.gov/pubmed/38025319
http://dx.doi.org/10.5339/qmj.2023.sqac.11

Ejemplares similares